CD19 Chimeric Antigen Receptor T-cell Shows Activity in Patients with B-cell Lymphoma Without CD19 Expression by Immunohistochemistry
Tao Wang(Second Military Medical University), Jian-Min Yang(Second Military Medical University)
Cited by 0
Related Papers
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
|Journal of Hematology & Oncology|2020|82
Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis
|Signal Transduction and Targeted Therapy|2024|34